Berberrubine inhibits Helicobacter pylori by inducing oxidative stress and impairing membrane integrity.
Study Design
- Tipo de Estudo
- In Vitro
- População
- None
- Intervenção
- Berberrubine inhibits Helicobacter pylori by inducing oxidative stress and impairing membrane integrity. MIC 11 μg/mL
- Comparador
- None
- Desfecho Primário
- anti-Helicobacter pylori activity
- Direção do Efeito
- Positive
- Risco de Viés
- Unclear
Abstract
Helicobacter pylori is a major gastric pathogen with increasing antibiotic resistance, creating an urgent need for new therapeutic strategies. We screened 37 pure compounds and 9 herbal extracts for anti-H. pylori activity and identified berberrubine as the most potent agent, with a minimum inhibitory concentration of 11 μg/ml. Berberrubine exhibited bacteriostatic effects by inducing oxidative stress and disrupting membrane integrity, as demonstrated by transcriptomic analysis, reactive oxygen species (ROS) accumulation, and structural damage, all of which were alleviated by the antioxidant N-acetylcysteine. Similar inhibitory effects were observed in Escherichia coli, indicating broader antimicrobial potential. This study provides the mechanistic evidence of berberrubine's activity against H. pylori, highlighting its promise as a candidate for development into alternative therapies to address antibiotic resistance.
Resumo Rápido
Berberrubine exhibited bacteriostatic effects by inducing oxidative stress and disrupting membrane integrity, as demonstrated by transcriptomic analysis, reactive oxygen species (ROS) accumulation, and structural damage, all of which were alleviated by the antioxidant N‐acetylcysteine.
Full Text
Used In Evidence Reviews
Similar Papers
Digestion · 2016
Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.
Gut · 1996
Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis.
Journal of nanobiotechnology · 2022
Oral administration of turmeric-derived exosome-like nanovesicles with anti-inflammatory and pro-resolving bioactions for murine colitis therapy.
Frontiers in endocrinology · 2024
The emerging role of oxidative stress in inflammatory bowel disease.
The British journal of nutrition · 2012
Omega-3 fatty acids and inflammatory bowel diseases - a systematic review.
Helicobacter · 2007